FDA places Atara’s Biothearapeutics’ cancer, autoimmune therapies on hold
The US drug regulator has put a clinical hold on Atara Biotherapeutics’ T-cell therapies for cancer and autoimmune diseases after issues were observed
Drugs
Health
Pharma
Daiichi Sankyo sets up robotic lab in US to speed up drug discovery
Daiichi Sankyo, the second-largest pharmaceutical company in Japan in terms of revenue, has set up a laboratory in the US for robotic development,
Drugs
Pharma
Research
New insights on GLP-1 drugs: Benefits and risks unveiled
HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their
Uncategorized
J&J’s nasal spray to treat major depressive disorder gets FDA nod
The US Food and Drug Administration has approved Johnson & Johnson’s nasal spray in adults who have had an inadequate response to at
Climate
Health
Medical
US to pull out from Paris Agreement that limits global warming
The US, the world’s second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.
Health
Medical
Pharma
US to withdraw from WHO after an executive order from Donald Trump
The US, the World Health Organization’s top donor, has decided to withdraw from the global health body, accusing it of “mishandling” the Covid-19
Health
Medical
Research
Muscle fat raises heart disease risk, independent of BMI, study finds
HQ Team January 20, 2024:People with fat stored within their muscles, known as intermuscular fat, face a significantly higher risk of serious cardiovascular
Health
Medical
Research
Major headway in depression study: 293 new genetic variants found
HQ Team January 20, 2025: Research has unveiled 293 new gene variants linked to major depressive disorder (MDD), significantly enhancing our understanding of
Health
Medical
Research
Study uncovers mechanism behind Huntington’s disease onset
HQ Team January 19, 2025: A study led by researchers from the Broad Institute, Harvard Medical School, and McLean Hospital has shed light
Drugs
Health
Pharma
AstraZeneca’s medicine to treat a type of breast cancer gets US nod
AstraZeneca Plc.’s antibody-drug conjugate for treating a certain type of breast cancer got approval from the US drug regulator, the company stated.